Please login to the form below

Not currently logged in
Email:
Password:

Redx poaches AstraZeneca senior executive

Lisa Anson joins the UK biotech as its CEO

Lisa AnsonDrug discovery and development group Redx Pharma has appointed its new chief executive officer in the form of Lisa Anson.

Anson, who was previously AstraZeneca’s UK president since 2012, also joins Redx’s board of directors, taking up both roles on 1 June.

With a 20-year career with AstraZeneca, Anson has held a variety of senior management roles at the pharmaceutical company, situated in both the US and UK, including global vice president oncology, and vice president of emerging brands, working closely with the research and development teams.

Ian Ross, executive chairman of Redx, said: “Lisa has been tasked by the board to lead the re-launch of the company and to take the steps necessary to build a substantial biotech company built upon an innovative science base, selectively acquiring additional assets.

“Lisa is a consummate business professional, who brings a wealth of relevant experience from the international pharmaceutical and biotech sector and I am confident that she is the right person to grow this company into a very excising and meaningful entity that has the potential to create both important new medicines for patients and generate significant value for shareholders."

27th April 2018

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics